|
"Pulmovet will provide the only complete medication treatment for heaves - A delivery device + bronchodilator + anti-inflammatory."
| The Device: The current EquineHalerTM (patented by Equine HealthCare and licensed to Pulmovet) will be specifically modified and patented as a unique drug delivery/medication combination. The EquineHaler is currently widely accepted by equine veterinarians as the most effective delivery system for equine inhalation medications. |
 |
 |
The Primary Medication: R-salbutamol (patented by Stirling Products Limited and licensed to Pulmovet) is a superior bronchodilator to racemic salbutamol that has already been approved in the USA. Compared to Clenbuterol the only approved medication for heaves, R-salbutamol has the potential to provide greater and faster onset of activity with reduced side-effects. |
| The Secondary Medication: to complement the R-salbutamol bronchodilator, Pulmovet will introduce a widely-accepted corticosteroid for treatment of inflammation associated with equine heaves. |
 |
Benefits of Medication Regime based on consumer requirements:
The Device:
- already marketed in Australia, Europe and the United States under the trade mark EquineHaler.
|
- faster, more effective and safer delivery system for respiratory drugs that does not obstruct the horse's airflow.
|
- accepted as the superior aerosol delivery system for horses.
|
- delivers a high concentration of drug where it is needed - in the airways.
|
- avoids high systemic concentrations of drugs (especially corticosteroids) that can have untoward effects.
|
|
The Medication:
- bronchodilator favoured as treatment for respiratory diseases in humans and not previously available to veterinarians.
|
- ten times less dose required by inhalation delivery compared to systematic delivery.
|
- bronchodilator has established history in human asthma and rarely causes side-effects (most common is sweating) and is rapid in action.
|
- combined medication regime of bronchodilator followed 15 minutes later by inhaled corticosteroid provides comprehensive treatment.
|
"Aerosol delivery of bronchodilators and corticosteroids will become the most common way to treat respiratory disorders like heaves." |
